Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events
Author:
- 1 June 2004
- journal article
- research article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 16 (S1) , S34-S37
Abstract
Vardenafil potently inhibits human phosphodiesterase 5 (PDE5) with an IC50 of 0.7 nM. Enhancement of nitric oxide (NO)-induced erections in rabbits by 0.1 mg/kg vardenafil is limited by its pharmacokinetic properties (Tmax=1 h; T1/2=1.2 h), although erectile effects have been observed after 7 h. In humans, vardenafil is rapidly absorbed (Tmax 40 min) and more slowly metabolized (T1/24 h), with an absolute bioavailability of 14.5% (vs 40% for sildenafil). Although the consumption of high-fat meals does not affect the drug's relative bioavailability, it retards intestinal absorption. Coadministration of CYP3A4 inhibitors such as ritonavir can affect hepatic metabolism. M1, an active metabolite of vardenafil, is a four-fold-less potent inhibitor of PDE5 than its parent compound, contributing approximately 7% to vardenafil's overall efficacy. The side effects of all selective PDE5 inhibitors commonly include vasodilation, small reductions in blood pressure, headache, and nasal congestion.Keywords
This publication has 18 references indexed in Scilit:
- Pro-erectile Effect of Vardenafil: In Vitro Experiments in Rabbits and In Vivo Comparison with Sildenafil in RatsEuropean Urology, 2003
- Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in RatsStroke, 2002
- A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunctionExpert Opinion on Investigational Drugs, 2002
- The Phosphodiesterase 5 Inhibitor Sildenafil Has No Effect on Cerebral Blood Flow or Blood Velocity, but Nevertheless Induces Headache in Healthy SubjectsJournal of Cerebral Blood Flow & Metabolism, 2002
- Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the ratNeuroscience, 2002
- Sildenafil for Male Erectile DysfunctionArchives of internal medicine (1960), 2002
- Evaluation of side effects of sildenafil in group of young healthy volunteersInternational Urology and Nephrology, 2001
- The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafilInternational Journal Of Impotence Research, 2001
- Modulation of Human Platelet Aggregation by the Phosphodiesterase Type 5 Inhibitor SildenafilJournal of Cardiovascular Pharmacology, 2001
- Sildenafil increases diclofenac antinociception in the formalin testEuropean Journal of Pharmacology, 2001